Elucid vs United Imaging uAI

CPT 75577 for quantitative coronary plaque analysis has applied since January 1, 2026, and Medicare's national average payment is about $1,012 in imaging centers and physician offices. That money goes to the performing site. Elucid bills providers per analysis and publishes no list price, and trained analysts segment the 3D model, with no turnaround time published. The FDA cleared PlaqueIQ as K241524 on September 12, 2024 for plaque quantification to support clinicians, and the FDA record does not extend that clearance to diagnosis of disease. A second PlaqueIQ 510(k), K261855, has a decision date of September 18, 2026.

A hospital imaging department buying CT, MR or PET/CT from United Imaging is the uAI buyer, with uAI Easy Triage ICH for non-contrast head CT (K242292), uAI EasyTriage-Rib and scanner-side reconstruction arriving in the same order. Plaque quantification and head CT triage are not alternatives, so the cardiology group weighing Elucid is deciding whether an analyst-segmented 3D model, billed per analysis, fits its coronary CT angiography workflow.